Designed for patient education, built to reduce clinic workload: New AI-powered patient platform eyejourney from Innoptix
Posted on 2/02/2026
When patients leave a consultation, they forget 80% of what they were told within 24 hours1 – and when critical information doesn’t stick, ophthalmology clinics are left managing anxious patients and a high administrative burden.
eyejourney is the solution.
Launching today, eyejourney is a personalised, AI-powered patient education platform designed to bring clarity, consistency and confidence to every stage of ophthalmic care.
eyejourney replaces panicked Google searches, generic websites and outdated printed flyers with a simple, clinic-branded digital journey that guides patients through their care. At its core, eyejourney uses cutting-edge AI generated video content to deliver powerful patient education for all ophthalmic procedures. Surgeons are empowered to create personalised videos, from an extensive library of templates, using their own digital avatars. Patients build familiarity from the very start of their journey – and have their questions answered by their trusted clinician long after the consultation ends, without taking up valuable chair time. Clinics retain full control through a simple dashboard, including the ability to track drop compliance, obtain electronic consent and monitor engagement with education.
“White coat syndrome is real, and it has a measurable impact on outcomes,” said Dr Stanley Windsor, creator of eyejourney and Head of Digital Health at Rayner.
“eyejourney was created in response to a growing burden on ophthalmology clinics, and our mission is to help them deliver the care they aspire to, without compromising quality. When patients truly understand their procedure, clinics run more smoothly and outcomes improve.”
eyejourney is available in multiple languages, with a dedicate team providing support throughout. Speak to the team this week at Faco Elche 2026, or book your demo at Eyejourney.ai
Contact your local Rayner representative for more information, or visit www.rayner.com/sophi
References
- Kessels, R. P. (2003). Patients’ memory for medical information. Journal of the Royal Society of Medicine, 96(5), 219-222.
About Innoptix
Building on the success of RayPRO, a leading digital patient reported outcomes tool, and RayTrace, Rayner’s premium online IOL calculator, Innoptix was developed in 2025 to provide agile, brand agnostic digital innovations for the ophthalmic community. For more information, visit innoptix.com.
About Rayner:
Since the implantation of the first Rayner intraocular lens by Sir Harold Ridley in 1949, Rayner has had the goal to improve vision and restore sight worldwide. Today, Rayner’s mission remains to deliver innovative and clinically superior ophthalmic products that respond to the expectations of our global customers to improve the sight and quality of life of their patients.
Headquartered in Worthing, United Kingdom, Rayner markets its medical devices, pharmaceuticals, and digital solutions globally through a network of distributors and includes direct sales teams in the United Kingdom, Eire, USA, Canada, Brazil, India, Poland, Australia, Germany, Austria, Switzerland, France, Italy, Spain, and Portugal.
Not all Rayner products are approved for sale in every country. Please contact your local Rayner distributor for details of which products are available in your area.
©2026 Rayner Group, all rights reserved. ‘Rayner’ ‘Innoptix’ and ‘eyejourney’ are proprietary marks of the Rayner Group. All other trademarks are property of their respective owners. Rayner, The Ridley Innovation Centre, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539 | EC 2026-04 EN